The ε4 allele of the Apolipoprotein E gene as a potential protective factor for exudative age-related macular degeneration

American Journal of Ophthalmology

Volumn 125, Issue 3, 1998, Pages 353-359

  Souied, Eric H ^a,b   Benlian, Pascale ^c   Amouyel, Philippe ^d   Feingold, Josue ^e   Lagarde, Jean Pierre ^f   Munnich, Arnold ^b   Kaplan, Josseline ^b   Coscas, Gabriel ^a   Soubrane, Gisèle ^a,g  

^a Clin Ophtalmol Univ de Creteil   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

^c HÔPITAL SAINT ANTOINE   (France)

^d INSTITUT PASTEUR DE LILLE   (France)

^e INSERM   (France)

^f Faculte de Medecine Pitie S   (France)

^g Spécialisation dans les industries alimentaires et biologiques   (France)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E4; APOLIPOPROTEIN E;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DRUSEN; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC RESISTANCE; GENOTYPE; HUMAN; LIPID COMPOSITION; LIPID METABOLISM; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RETINA EXUDATE; RETINA MACULA AGE RELATED DEGENERATION; ALLELE; CHOROID; EXUDATE; GENETICS; MIDDLE AGED; NEOVASCULARIZATION (PATHOLOGY); RETINA MACULA DEGENERATION; RISK FACTOR; VASCULARIZATION;

AGED; AGED, 80 AND OVER; ALLELES; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; CHOROID; EXUDATES AND TRANSUDATES; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; MACULAR DEGENERATION; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; RETINAL DRUSEN; RISK FACTORS;

EID: 0032014838     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9394(99)80146-9     Document Type: Article

References (33)

1. 1. Hyman L. Epidemiology of eye diseases in the elderly. Eye 1987;1:330-341.
2. 2. Gass JMD. Drusen and disciform macular degeneration: a preliminary study. Ann Ophthalmol 1973;90:206-217.
3. 3. Seddon JM, Ajani UA, Mitchell BD. Familial aggregation of age-related maculopathy. Am J Ophthalmol 1997;123: 199-206.
4. 4. Pauleikhoff D, Barondes MJ, Minassian D, Chisholm IH, Bird AC. Drusen as risk factors in age-related macular disease. Am J Ophthalmol 1990;109:38-43.
5. 5. Klein R, Kein BEK, Jensen SC, Meuer SM. The five-year incidence and progression of age-related maculopathy. Ophthalmology 1997;104:7-21.
6. 6. Bressler SB, Silva JC, Bressler NM, Alexander J, Green WR. Clinicopathologic correlations of occult choroidal neovascularization in age-related macular degeneration. Arch Ophthalmol 1992;110:827-832.
7. 7. Pauleikhoff D, Harper A, Marshall J, Bird AC. Ageing changes in Bruch's membrane. Ophthalmology 1990;97: 171-178.
8. 8. Bird AC, Marshall J. Retinal epithelial detachments in the elderly. Trans Ophthalmol Soc UK 1986;105:674-682.
9. 9. Weisgraber KH, Roses A, Strittmatter WJ. The role of apolipoprotein E in the nervous system. Curr Opin Lipidol 1994;5:110-116.
10. 10. Das HK, McPherson J, Bruns G, Karathanasis SK, Breslow JL. Isolation, characterization, and mapping to chromosome 19 of the human apolipoprotein E gene. J Biol Chem 1985;260:6240-6247.
11. 11. Schächter F, Faure-Delanef L, Guénot F, et al. Genetic associations with human longevity at the ApoE and ACE loci. Nat Genet 1994;6:29-32.
12. 12. Davignon J, Gregg RE, Sing CF. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 1988;8:1-21.
13. 13. Van Duijn CM, De Knijff P, Cruts M, et al. Apolipoprotein E4 allele in a population-based study of early onset Alzheimer's disease. Nat Genet 1994;7:74-78.
14. 14. International ARM Epidemiological Study Group. An international classification and grading system for age-related maculopathy and age-related macular degeneration. Surv Ophthalmol 1995;39:367-374.
15. 15. Bickeböller H, Campion D, Brice A, et al. Apolipoprotein E and Alzheimer disease: genotype-specific risks by age and sex. Am J Hum Genet 1997;60:439-446.
16. 16. Hallman DM, Boerwinkl E, Saha N, et al. The apolipoprotein E polymorphism: a comparison of allele frequency and effects in nine populations. Am J Hum Genet 1991;49: 338-349.
17. 17. Amouyel P, Richard F, Cottel D, Amant C, Codron V, Helbecque N. The deletion allele of the angiotensin I-converting enzyme gene as a genetic susceptibility factor for cognitive impairment. Neurosci Lett 1996;217:203-205.
18. 18. Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with Hhal. J Lipid Res 1990;31:545-548.
19. 19. Klein ML, Mauldin WM, Stoumbos. Heredity and age related macular degeneration. Arch Ophthalmol 1994;112: 932-937.
20. 20. Silvestri G, Johnston PB, Hughes AE. Is genetic predisposition an important risk factor in age-related macular degeneration? Eye 1994;8:564-568.
21. 21. Piguet B, Wells JA, Palmvang IB, Wormald R, Chisholm IH, Bird A. Age-related Bruch's membrane change: a clinical study of the relative role of heredity and environment. Br J Ophthalmol 1993;77:400-403.
22. 22. Klaver CC, van Duyn CM, Hofman A, van Broeckhoven C, Wolfs RC, De Jong PT. Does apolipoprotein E polymorphism play a role in age-related macular degeneration? ARVO abstracts. Invest Ophthalmol Vis Sci 1996;37(3,suppl):S796.
23. 23. Cruickshanks KJ, Hamman RF, Nondahl DM, Shetterly SM. Cardiovascular risk factors and early age-related maculopathy in Colorado non-Hispanic whites. ARVO abstracts. Invest Ophthalmol Vis Sci 1997;38(3,suppl):S471.
24. 24-De La Paz M, Pericak-Vance MA, Haines J, et al. Studies of apolipoprotein E (APOE) and age-related macular degeneration. ARVO abstracts. Invest Ophthalmol Vis Sci 1997; 38(3,suppl):S796.
25. 25. Coscas G. Subretinal neovascularization in senile macular degeneration. Eye 1987;1:364-378.
26. 26. Coscas G, Green WR, Marshall J, Ryan SJ, Soubrane G. Dégénérescences maculaires atrophique liées a l'age. In: Coscas G, editor. Dégénérescences maculaires acquises liées a l'age et neovaisseaux sous rétiniens. Paris: Masson, 1991; 191-203.
27. 27. Small KW. Molecular genetics of macular degeneration. In: Wings JL, editor. Molecular genetics of ocular disease. New York, New York: Wiley-Liss, 1995:127-137.
28. 28. Mimoun G, Soubrane G, Coscas G. Les drusen maculaires. J Fr Ophthalmol 1990;13:511-530.
29. 29. Boerwinkle E, Visvikis S, Welsh D, Steinmetz J, Hanash SM, Sing Cf. The use of measured genotype information in the analysis of quantitative phenotypes in man, II: the role of the apolipoprotein E polymorphism in determining levels, variability, and covariability of cholesterol, betalipoprotein, and triglycerides in a sample of unrelated individuals. Am J Med Genet 1987;27:567-582.
30. 30. Moore DJ, Hussain AA, Marshall J. Senescent reduction in the macromolecular permeability of Bruch's membrane. ARVO abstracts. Invest Ophthalmol Vis Sci 1997; 38(3,suppl):S353.
31. 31. Pauleikhoff D, Chen JC, Chisholm IH, Bird AC. Choroidal perfusion abnormality with age-related Bruch's membrane change. Am J Ophthalmol 1990;109:211-217.
32. 32. Weisgraber KH. Apolipoprotein E distribution among human plasma lipoprotein; role of the cysteine-arginine interchange at residue 112. J Lipid Research 1990;81:1503-1508.
33. 33. Lorent K, Overbergh L, Moechars D, Destrooper B, van Leuven F, van Berghe H. Expression in mouse embryos and in adult mouse brain of the three members of the amyloid precursor family, of the α2 macroglobulin receptor/LDL receptor-related protein and of its ligands apolipoprotein E, lipoprotein lipase, α2 macroglobulin and the 40000-molecular weight receptor-associated protein. Neuroscience 1995; 65:1009-1025.